Profil
Chris Liang is the founder of Xcovery Vision LLC, founded in 2010.
Dr. Liang is also the founder of Xcovery Holding, Inc.,Tyrogenex, Inc.,Hangzhou Highlight Pharmaceutical Co., Ltd...
Dr. Liang was Principal at Sugen, Inc.
Aktiva positioner av Chris Liang
| Företag | Position | Start |
|---|---|---|
Xcovery Holding, Inc.
Xcovery Holding, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology focused bio-pharmaceutical company | Grundare | - |
HighlightLL Pharmaceutical
HighlightLL Pharmaceutical Pharmaceuticals: MajorHealth Technology Manufactures medicines for neurodegenerative diseases | Verkställande Direktör | 2020-07-01 |
Tidigare kända positioner av Chris Liang
| Företag | Position | Slut |
|---|---|---|
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Företagsledare/Principal | - |
Xcovery Vision LLC | Grundare | - |
Tyrogenex, Inc.
Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Offers drug discovery and development focused on small molecule kinase inhibitors | Grundare | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
Xcovery Holding, Inc.
Xcovery Holding, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology focused bio-pharmaceutical company | Health Technology |
Tyrogenex, Inc.
Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Offers drug discovery and development focused on small molecule kinase inhibitors | Health Technology |
Xcovery Vision LLC | |
HighlightLL Pharmaceutical
HighlightLL Pharmaceutical Pharmaceuticals: MajorHealth Technology Manufactures medicines for neurodegenerative diseases | Health Technology |
















